Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: McDonald CM … Marban E Journal: The Lancet Published: 2026-07-29 DOI: https://doi.org/10.1016/S0140-6736(26)01385-1